Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibody Dynamics and Durability in Coronavirus Disease-19

Clinics in Laboratory Medicine(2021)10.1016/j.cll.2021.10.004Source: DataRank Database

Antibody Dynamics and Durability in Coronavirus Disease-19 is a research paper published in Clinics in Laboratory Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.23)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Duane R. Wesemann ORCID,Adam Zuiani ORCID

Live enrichment

PubMed:35153050 PMC:PMC8563365 OpenAlex:https://openalex.org/W3209001247

NIAID NIH HHS

Grant: R01 AI139538

NIAID NIH HHS

Grant: P01 AI165072

NIAID NIH HHS

Grant: R01 AI170715

National Institutes of Health

Grant: 1P01AI165072-01

Discovering Durable Pan-Coronavirus Immunity

National Institutes of Health

Grant: 5R01AI139538-03

Elucidating Germinal Center-Mediated Antibody Evolution

NIH

FWCI

1.23

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8563365

publisherhttps://api.elsevier.com/content/article/PII:S0272271221000846?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0272271221000846?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cll.2021.10.004

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralHumansImmunoglobulin AImmunoglobulin GImmunoglobulin M

Keywords

PandemicAntibodyImmunologyVirusCoronavirus disease 2019 (COVID-19)CoronavirusPopulationDiseaseVirologyMedicineImmunizationTransmission (telecommunications)BiologyInfectious disease (medical specialty)Internal medicineEnvironmental healthAntibodiesIgGIgMPlasma cellsDurabilityIGAGerminal CenterCovid-19Immunoglobulin MSARS-CoV-2Immunoglobulin GHumansAntibodies, ViralArticleImmunoglobulin A

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being